BonAlive Biomaterials Ltd is an emerging leader in the field of implantable medical devices for bone regeneration. The focus is to provide world-leading biomaterial solutions for the treatment of chronically infected bone. BonAlive ® products are available in Europe, Middle East, Asia-Pacific, Africa, Brazil and the USA through a professional distributor network. The clinical use of BonAlive ® is supported by a twenty year research history including several randomized prospective trials in the field of spine, benign bone tumor and trauma surgery. More than fifty peer reviewed articles have been published about BonAlive ®.
About Olympus Biotech International Limited
Olympus Biotech was established in December, 2010 as a wholly owned company of Olympus Corporation. The vision of Olympus Biotech is to improve the patient Quality of Life by developing and distributing Regenerative Medicine that stimulates the intrinsic healing capacity in the living body. Olympus Biotech provides minimally-invasive regenerative therapies for bone and soft tissue including growth factors, scaffolds and cell harvesting technologies as well as tools for access, placement and delivery.
For questions or additional information, please contact:Olympus Biotech International Limited Dirk Dembski Vice President Marketing and Business Development Olympus Biotech International Mobile +49-172-2492700 email@example.com BonAlive Biomaterials Ltd: Fredrik Ollila, PhD Chief Executive Officer BonAlive Biomaterials Ltd Mobile +358(0)400-931-209 Fax +358(0)421-917-744-00 firstname.lastname@example.org SOURCE BonAlive Biomaterials Ltd